| Rick Ferris, DO | |
|
3402 William Flynn Hwy, Allison Park, PA 15101-3801 | |
| (412) 486-3181 | |
| (412) 487-3565 |
| Full Name | Rick Ferris |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 38 Years |
| Location | 3402 William Flynn Hwy, Allison Park, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962501221 | NPI | - | NPPES |
| 0012475400001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | OS006340L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Magee Womens Hospital Of Upmc Health System | Pittsburgh, PA | Hospital |
| West Penn Hospital | Pittsburgh, PA | Hospital |
| Butler Memorial Hospital | Butler, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Butler Medical Providers | 7416840160 | 308 |
| Pittsburgh Gynob Inc | 0345212536 | 6 |
News Archive
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
People who survived the Indian Ocean tsunami or lost loved ones in the disaster went through a complex process of trauma and grief, according to research published in the latest Journal of Advanced Nursing.
Research by bioscientists at the University of Kent and the University of Queensland is expected to pave the way for new approaches to kill bacteria that no longer respond to conventional antibiotics.
A new analysis suggests that broader statin use among adult patients may be a cost-effective way to prevent heart attack and stroke. The Stanford University School of Medicine study also found that using a popular test - a screening for high sensitivity C-reactive protein, or CRP - to identify patients who may benefit from statin therapy would be cost-effective, but only under certain scenarios.
Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell.
› Verified 1 days ago
| Entity Name | Butler Medical Providers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619493046 PECOS PAC ID: 7416840160 Enrollment ID: O20040205000830 |
News Archive
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
People who survived the Indian Ocean tsunami or lost loved ones in the disaster went through a complex process of trauma and grief, according to research published in the latest Journal of Advanced Nursing.
Research by bioscientists at the University of Kent and the University of Queensland is expected to pave the way for new approaches to kill bacteria that no longer respond to conventional antibiotics.
A new analysis suggests that broader statin use among adult patients may be a cost-effective way to prevent heart attack and stroke. The Stanford University School of Medicine study also found that using a popular test - a screening for high sensitivity C-reactive protein, or CRP - to identify patients who may benefit from statin therapy would be cost-effective, but only under certain scenarios.
Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell.
› Verified 1 days ago
| Entity Name | Pittsburgh Gynob Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316044936 PECOS PAC ID: 0345212536 Enrollment ID: O20040809000826 |
News Archive
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
People who survived the Indian Ocean tsunami or lost loved ones in the disaster went through a complex process of trauma and grief, according to research published in the latest Journal of Advanced Nursing.
Research by bioscientists at the University of Kent and the University of Queensland is expected to pave the way for new approaches to kill bacteria that no longer respond to conventional antibiotics.
A new analysis suggests that broader statin use among adult patients may be a cost-effective way to prevent heart attack and stroke. The Stanford University School of Medicine study also found that using a popular test - a screening for high sensitivity C-reactive protein, or CRP - to identify patients who may benefit from statin therapy would be cost-effective, but only under certain scenarios.
Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rick Ferris, DO 3402 William Flynn Hwy, Allison Park, PA 15101-3801 Ph: (412) 486-3181 | Rick Ferris, DO 3402 William Flynn Hwy, Allison Park, PA 15101-3801 Ph: (412) 486-3181 |
News Archive
Adocia, a biotechnology company specializing in the development of ‘best-in-class' medicines from already approved therapeutic proteins, announced today that it had agreed with Eli Lilly and Company not to continue further joint research under the licensing agreement signed in December 2011 relating to use of Adocia's BioChaperone(R) technology for the formulation of fast acting insulin analog formulated with the BioChaperone(R) technology. Consequently, the two companies have terminated the collaboration.
People who survived the Indian Ocean tsunami or lost loved ones in the disaster went through a complex process of trauma and grief, according to research published in the latest Journal of Advanced Nursing.
Research by bioscientists at the University of Kent and the University of Queensland is expected to pave the way for new approaches to kill bacteria that no longer respond to conventional antibiotics.
A new analysis suggests that broader statin use among adult patients may be a cost-effective way to prevent heart attack and stroke. The Stanford University School of Medicine study also found that using a popular test - a screening for high sensitivity C-reactive protein, or CRP - to identify patients who may benefit from statin therapy would be cost-effective, but only under certain scenarios.
Johnson & Johnson and Crucell today announced that the European Commission has granted approval for Johnson & Johnson's proposed acquisition of Crucell.
› Verified 1 days ago
Dr. Jennifer Hope Gallagher, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3402 William Flynn Hwy, Allison Park, PA 15101 Phone: 412-486-3181 Fax: 412-487-3565 | |
Gary Bergman, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3402 William Flynn Hwy, Allison Park, PA 15101 Phone: 412-486-3181 Fax: 412-487-3565 | |
Robin Mcguire, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3402 William Flynn Hwy, Allison Park, PA 15101 Phone: 412-486-3181 Fax: 412-487-3565 | |
Ingrid Wecht, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3402 William Flynn Hwy, Allison Park, PA 15101 Phone: 412-486-3181 Fax: 412-487-3565 | |
Charles A Perryman, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3402 William Flynn Hwy, Allison Park, PA 15101 Phone: 412-486-3181 Fax: 412-487-3565 | |
Dr. Bernard J Riley, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3402 Route 8, Allison Park, PA 15101 Phone: 412-486-3181 Fax: 412-486-5297 |